New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
The Society of Thoracic Surgeons National Intermacs Database Risk Model for Durable Left Ventricular Assist Device Implantation.
ÌÇÐÄ´«Ã½
The Society of Thoracic Surgeons National Intermacs Database Risk Model for Durable Left Ventricular Assist Device Implantation. The Annals of thoracic surgery Pagani, F. D., Singletary, B., Cantor, R., Mehaffey, J. H., Nayak, A., Teuteberg, J., Shah, P., Cowger, J., Vega, J. D., Goldstein, D., Kurlansky, P. A., Stehlik, J., Jacobs, J., Shahian, D., Habib, R., Dardas, T. F., Kirklin, J. K. 2025Abstract
Statistical risk models for durable left ventricular assist device (LVAD) implantation inform candidate selection, quality improvement, and evaluation of provider performance. We developed a 90-day mortality risk model utilizing The Society of Thoracic Surgeons National Intermacs Database (STS Intermacs).STS Intermacs was queried for primary durable LVAD implants from 1/ 2019 - 9/2023. Multivariable logistic regression was used to derive a model based upon pre-implant risk factors using derivation (2019-2021 implants) and validation (2022-2023 implants) cohorts. Model performance (derivation and validation cohorts) was assessed using C-statistics, Brier Scores, and calibration plots. A refined model (all patients) was generated to calculate observed/expected [O/E, 95% confidence intervals (CI)] ratios for each center.The study population consisted of 11,342 patients from 2019-2023 sequentially divided in time into derivation (n=6,775) and validation (n=4,567). Ninety-day mortality was 8.0% (9.2% in derivation cohort vs. 7.4% in validation cohort; p=0.001). Logistic regression applied to derivation and validation cohorts produced similar discrimination (area under the curve (AUC) 0.714, CI: 0.69-0.74 and AUC 0.707, CI: 0.67-0.72, respectively) and calibration (Brier score .08 vs .07), with overestimation of risk among patients with predicted risk > 0.4. The O/E analysis identified 22 (12.5%) centers with worse-than-expected mortality with a CI > 1.0 and 14 centers (8.0%) with better-than-expected mortality with a CI < 1.0 (all p < 0.05).The STS Intermacs Risk Model demonstrated satisfactory discrimination and calibration. This tool may be used to inform candidate selection, facilitate quality improvement, and assess provider performance.
View details for
View details for